Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Linda S Elting

Biographic Data

ID5535559
NAMELinda S Elting
GIVEN NAMESLinda S
FAMILY NAMEElting
SIGNATUREELTING L S
AFFILIATIONSThe University of Texas MD Anderson Cancer Center
ORCID0000-0002-9058-1827
VERIFIEDNo
TOTAL WORKS2
TOTAL CITATIONS0
WORKS AS AUTHOR2
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2009
LATEST PUBLICATION YEAR2015
H-INDEX0
  • Variation in Intensity and Costs of Care by Payer and Race for Patients Dying of Cancer in Texas

    B Ashleigh Guadagnolo, Kai-Ping Liao et al.•ARTICLE•Medical Care•2015•References: 18

    PURPOSE: To investigate end-of-life care for Medicaid, Medicare, and dually eligible beneficiaries dying of cancer in Texas. METHODS: We analyzed the Texas Cancer Registry (TCR)-Medicaid and TCR-Medicare linked databases' claims data for 69,572 patients dying of cancer in Texas from 2000 to 2008. We conducted regression models in adjusted analyses of cancer-directed and acute care and total costs of care (in 2014 dollars) in the last 30 days of l…

  • Factors Associated With Immunotherapy Use Among Newly Diagnosed Cancer Patients

    Ya-Chen Tina Shih, Linda S Elting et al.•ARTICLE•Medical Care•2009•References: 43

    CONTEXT: Immunotherapy represents a newer modality for cancer treatment with substantial health benefits. However, the high costs of immunotherapy may create access barriers. OBJECTIVE: To examine factors associated with the utilization of immunotherapy among newly diagnosed cancer patients. DESIGN AND SETTING: Analysis of a large national cancer registry data, the National Cancer Data Base, that represents approximately 75% of newly diagnosed ca…

No prominent works on this page.

  • Factors Associated With Immunotherapy Use Among Newly Diagnosed Cancer Patients

    Ya-Chen Tina Shih, Linda S Elting et al.•ARTICLE•Medical Care•2009•References: 43

    CONTEXT: Immunotherapy represents a newer modality for cancer treatment with substantial health benefits. However, the high costs of immunotherapy may create access barriers. OBJECTIVE: To examine factors associated with the utilization of immunotherapy among newly diagnosed cancer patients. DESIGN AND SETTING: Analysis of a large national cancer registry data, the National Cancer Data Base, that represents approximately 75% of newly diagnosed ca…

  • Variation in Intensity and Costs of Care by Payer and Race for Patients Dying of Cancer in Texas

    B Ashleigh Guadagnolo, Kai-Ping Liao et al.•ARTICLE•Medical Care•2015•References: 18

    PURPOSE: To investigate end-of-life care for Medicaid, Medicare, and dually eligible beneficiaries dying of cancer in Texas. METHODS: We analyzed the Texas Cancer Registry (TCR)-Medicaid and TCR-Medicare linked databases' claims data for 69,572 patients dying of cancer in Texas from 2000 to 2008. We conducted regression models in adjusted analyses of cancer-directed and acute care and total costs of care (in 2014 dollars) in the last 30 days of l…

Cancer (2 works) · Cancer registry (2 works) · Economic and Financial Impacts of Cancer (2 works) · Internal Medicine (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Acute care (1 work) · Bevacizumab (1 work) · Cancer Immunotherapy and Biomarkers (1 work) · Cetuximab (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae